Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Anaemia
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Anaemia
    Darbepoetin Alfa Risks Outweigh Benefits for Patients With CKD, Diabetes, and Anaemia: Presented at Renal Week 2009 - (DGDispatch)
    A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease - (N Engl J Med)
    TopAbstracts in Anaemia 10/28/2009 - (DGNews)
    TopAbstracts in Anaemia 10/14/2009 - (DGNews)
    TopAbstracts in Anaemia 09/30/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Anaemia
    • State of the Art in Managing Anemia in Chronic Kidney Disease
    • Current Challenges in Managing CKD-Related Anemia
    • Optimizing Hemoglobin in CKD-Related Anemia
    • A Practical Approach to Minimize the Burden of CKD-Induced Anemia
      Assuring the Safe and Appropriate Management of Anemia in Two Patient Populations: Cancer and Chronic Kidney Disease

      Webcasts/CME archive

       Recent cases - Anaemia
        A Patient with Haemolytic Anaemia Diagnosed After Thirty Years
        Severe Anemia From Bedbugs
        Orthodontic Management of Traumatic Avulsion of Permanent Incisors in a Child With Sickle Cell Anaemia: A Case Report
        Celiac Disease: It's More Common Than You Think
        A Rare Presentation of Micro-Angiopathic Haemolytic Anaemia in a Critically Ill Patient: A Case Report

        Cases archive
          




        my personal edition > anaemia > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Laparoscopic Splenectomy Safe, Effective for Autoimmune Haemolytic Anaemia in Chronic Lymphocytic Leukaemia

        A DGReview of :"Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: A case series and review of the literature"
        American Journal of Hematology

        03/11/2004
        By Mary Beth Nierengarten


        Laparoscopic splenectomy is both safe and effective in patients with chronic lymphocytic leukaemia (CLL) with autoimmune haemolytic anaemia that is refractory to medical management, report researchers from the United States.

        Laparoscopic splenectomy is an alternative treatment for patients who fail medical management for autoimmune haemolytic anaemia; however, the clinical utility of this procedure in patients with CLL is uncertain.

        In this study, John Hill, MD, and colleagues, Cleveland Clinic Foundation, Ohio, retrospectively evaluated the safety and efficacy of laparoscopic splenectomy in 9 patients with CLL with autoimmune haemolytic anaemia. The patients had been previously treated with alkylating agents and/or purine analogues for CLL. All had failed initial treatment with corticosteroids for autoimmune haemolytic anaemia, and 5 patients also failed intravenous immunoglobulin treatment.

        Overall, 78% of patients achieved a complete response of their autoimmune haemolytic anaemia after splenectomy. One of these patients relapsed at 12 weeks. At a mean follow-up of 24 months (range of 9-43 months), therefore, 67% remained in complete remission. Of the 2 patients who did not respond, 1 died 19 days after surgery with no evidence of response and 1 showed no response to treatment 5 months after splenectomy.

        Treatment was well tolerated, with no immediate postoperative complications seen in 78% of the patients. In 2 patients who developed complications, 1 died of complications of Hodgkin's disease 19 days after surgery and 1 developed pneumonia. Splenectomy had no effect on preoperative immune-mediated thrombocytopenia documented in 2 patients who achieved complete response after splenectomy.

        The authors conclude that most patients with CLL with autoimmune haemolytic anaemia can expect some response from laparoscopic splenectomy, as well as durable remissions indicative of cure. However, they add that these good results are tempered by the lack of effect splenectomy had on preoperative immune-mediated thrombocytopenia in 2 patients, as well as by the fact that all long-term responders were subsequently treated further for CLL.

        Am J Hematol 2004 Mar;75:3:134-8. "Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: A case series and review of the literature"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send